Filters close
Newswise: Spotlight on Rare Diseases: Gallbladder and Bile Duct Cancers
Released: 30-Jan-2023 4:35 PM EST
Spotlight on Rare Diseases: Gallbladder and Bile Duct Cancers
Rutgers Cancer Institute of New Jersey

Despite their rarity, it’s important to know the signs and symptoms of bile duct and gallbladder cancers.

Newswise: Cancer Survivors may be at Risk for Heart Disease
Released: 30-Jan-2023 11:05 AM EST
Cancer Survivors may be at Risk for Heart Disease
Rutgers Cancer Institute of New Jersey

The bottom line: before, during and after cancer treatment, heart health is critical. Andrew M. Evens, DO, MBA, MSc, associate director for Clinical Services at Rutgers Cancer Institute of New Jersey and medical director of the Oncology Service Line at RWJBarnabas Health, is a participating physician in the Cardio-Oncology Program at Rutgers Cancer Institute of New Jersey, the state’s leading cancer program, in partnership with RWJBarnabas Health, shares more on the topic.

Newswise: Cancer Prevention Experts Provide Top Tips for Reducing Cancer Risk
Released: 30-Jan-2023 11:05 AM EST
Cancer Prevention Experts Provide Top Tips for Reducing Cancer Risk
Rutgers Cancer Institute of New Jersey

Elisa V. Bandera, MD, PhD and Carolyn J. Heckman, PhD, co-leaders of the Cancer Prevention and Control Research Program at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, together with RWJBarnabas Health, share their top tips for cancer prevention during National Cancer Prevention Month.

Newswise: Investigators Explore Impact of Cigarette Smoking and Alcohol Consumption on Black Breast Cancer Survivors
20-Jan-2023 3:30 PM EST
Investigators Explore Impact of Cigarette Smoking and Alcohol Consumption on Black Breast Cancer Survivors
Rutgers Cancer Institute of New Jersey

In a new study published by JAMA Network Open, Dr. Elisa Bandera, Dr. Nur Zeinomar from Rutgers Cancer Institute of New Jersey and colleagues found that a higher risk of mortality in Black breast cancer survivors is associated with a history of cigarette smoking along with regular alcohol consumption at the time of diagnosis.

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Data at the 2023 ASCO Gastrointestinal (GI) Cancers Symposium
Released: 12-Jan-2023 2:45 PM EST
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Data at the 2023 ASCO Gastrointestinal (GI) Cancers Symposium
Rutgers Cancer Institute of New Jersey

Physician experts from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will be presenting the latest innovations in the study, diagnosis and treatment of gastrointestinal cancers at the ASCO GI Cancers Symposium from January 19-21.

Newswise: Study Uncovers Triple Immunotherapy Combination as Potential Treatment for Pancreatic Cancer
Released: 3-Jan-2023 4:35 PM EST
Study Uncovers Triple Immunotherapy Combination as Potential Treatment for Pancreatic Cancer
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, in collaboration with investigators from MD Anderson Cancer Center, discovered a novel triple immunotherapy combination, targeting checkpoints on both T cells and myeloid suppressor cells, that dramatically improved anti-tumor responses by reprogramming the tumor microenvironment in preclinical models of PDAC.

Newswise: What's the Connection Between HPV and Cervical Cancer? And More Questions You’re Reluctant to Ask
Released: 28-Dec-2022 8:05 AM EST
What's the Connection Between HPV and Cervical Cancer? And More Questions You’re Reluctant to Ask
Rutgers Cancer Institute of New Jersey

Cervical cancer is often stigmatized due to its association with human papilloma virus (HPV), a sexually transmitted infection, however, HPV is extremely common, affecting most adults. Some people may also feel uncomfortable asking their doctor about sexual health .James K. Aikins, Jr., MD, FACOG, FACS, chief of Gynecologic Oncology at Rutgers Cancer Institute of New Jersey, answers questions about HPV, cervical cancer and more.

Newswise: Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma
6-Dec-2022 10:05 AM EST
Investigators Develop Model to Predict Overall Survival in Adults Diagnosed with Advanced Stage Hodgkin Lymphoma
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and Tufts Medical Center Collaboration Published in Journal of Clinical Oncology

Newswise: How Winter Weather Impacts Blood Donations— and How You Can Help
Released: 7-Dec-2022 10:20 AM EST
How Winter Weather Impacts Blood Donations— and How You Can Help
Rutgers Cancer Institute of New Jersey

Blood donations typically dwindle in the winter months, and are needed for cancer patients. Blood and Marrow Transplant Coordinator at Rutgers Cancer Institute of New Jersey shares what everyone should know about donating blood.

Newswise: Navigating Seasonal Affective Disorder and Cancer this Winter
Released: 7-Dec-2022 10:20 AM EST
Navigating Seasonal Affective Disorder and Cancer this Winter
Rutgers Cancer Institute of New Jersey

Advise from Nina Debrot, MSW, LSW, social worker at Rutgers Cancer Institute, on how cancer patients and their families and caregivers can manage SAD.

Newswise: Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
Released: 17-Nov-2022 11:50 AM EST
Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Daniel Herranz Benito, PharmD, PhD, resident researcher at Rutgers Cancer Institute of New Jersey, has received a five-year, $600,000 award from the Leukemia and Lymphoma Society (LLS) to support ongoing research efforts in T-cell acute lymphoblastic leukemia (T-ALL).

Newswise: Meet Holiday Stress with Mindfulness
Released: 16-Nov-2022 10:55 AM EST
Meet Holiday Stress with Mindfulness
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey social worker shares how everyone can use mindfulness to cope with cancer during the holidays.

Newswise: Jack and Sheryl Morris Cancer Center Topping Off Ceremony
Released: 2-Nov-2022 5:05 PM EDT
Jack and Sheryl Morris Cancer Center Topping Off Ceremony
Rutgers Cancer Institute of New Jersey

Ceremony Marks the Completion of the Steel Construction Phase

Released: 1-Nov-2022 10:05 AM EDT
Do Pancreatic Cysts Become Cancerous?
Rutgers Cancer Institute of New Jersey

Although some pancreas cysts are benign, the majority are pre-cancerous and are the most common identifiable precursor to pancreatic cancer.

Newswise: Stomach Cancer Is a Health Priority Among Asian Americans
Released: 31-Oct-2022 4:45 PM EDT
Stomach Cancer Is a Health Priority Among Asian Americans
Rutgers Cancer Institute of New Jersey

Haejin In, MD, MPH, MBA, FACS, FSSO, is chief diversity officer, associate director for Diversity, Equity and Inclusion, and surgical oncologist at Rutgers Cancer Institute of New Jersey, shares the facts, the warning signs and concerns for the disease in Asian Americans.

Newswise: Disparities in Lung Cancer Detection: Moving Toward Equity & Inclusion
Released: 31-Oct-2022 4:15 PM EDT
Disparities in Lung Cancer Detection: Moving Toward Equity & Inclusion
Rutgers Cancer Institute of New Jersey

According to the American Lung Association, Black Americans, Latinos, Asian Americans or Pacific Islanders and Indigenous people who are diagnosed with lung cancer face worse outcomes compared to white Americans because they are less likely to be diagnosed early. Rutgers Cancer Institute expert shares how these disparities are being addressed and where to find cancer screening resources.

Newswise: The Impact of Lung Cancer on the Hispanic Community
Released: 31-Oct-2022 3:50 PM EDT
The Impact of Lung Cancer on the Hispanic Community
Rutgers Cancer Institute of New Jersey

According to the 2021-2023 edition of the American Cancer Society’s Cancer Facts and Figures for Hispanic/Latino People, about 6,000 Hispanic men and 5,800 Hispanic women are expected to be diagnosed with cancer of the lung and 3,200 Hispanic men and 2,300 Hispanic women are expected to die from the disease this year. Expert from Rutgers Cancer Institute shares what the Hispanic community needs to know about the disease.

Newswise: Exploring New Cancer Therapies that use a Patient’s Immune System to Fight Tumors
Released: 19-Oct-2022 11:05 AM EDT
Exploring New Cancer Therapies that use a Patient’s Immune System to Fight Tumors
Rutgers Cancer Institute of New Jersey

Approximately 500 healthy volunteers with no history of cancer are being sought to contribute blood cells that may be used in the development of cancer clinical trials.

Newswise: It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Released: 11-Oct-2022 2:05 PM EDT
It’s Flu Season Again: Here’s What Cancer Patients Need to Know
Rutgers Cancer Institute of New Jersey

Flu season is here. Rutgers Cancer Institute expert shares what cancer patients and their families need to know.

Newswise: Researchers Find Tumor Microbiome Interactions May Identify New Approaches for Pancreatic Cancer Treatment
5-Oct-2022 9:00 AM EDT
Researchers Find Tumor Microbiome Interactions May Identify New Approaches for Pancreatic Cancer Treatment
Rutgers Cancer Institute of New Jersey

Investigators from Rutgers Cancer Institute of New Jersey examined the microbiome of pancreatic tumors and identified particular microorganisms at single-cell resolution that are associated with inflammation and with poor survival. According to the researchers, these microorganisms may be new targets for earlier diagnosis or treatment of pancreatic cancer.

Newswise: Robert Wood Johnson University Hospital Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
Released: 4-Oct-2022 12:35 PM EDT
Robert Wood Johnson University Hospital Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
Rutgers Cancer Institute of New Jersey

The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS), has granted Three-Year Accreditation to the cancer program at Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health Facility, in partnership with Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center.

Newswise: Neil Palmisiano, MD, Appointed as Deputy Director of Phase 1 Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute of New Jersey
Released: 3-Oct-2022 7:05 AM EDT
Neil Palmisiano, MD, Appointed as Deputy Director of Phase 1 Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey

Further enhancing its focus on providing outstanding, innovative and compassionate care for cancer patients, Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only NCI-designated Comprehensive Cancer Center togetherwith RWJBarnabas Health, are welcoming a new leader to its team of internationally recognized physicians and researchers.

Newswise: Liver Cancer: Excessive Alcohol Use and Other Risks
Released: 30-Sep-2022 3:05 PM EDT
Liver Cancer: Excessive Alcohol Use and Other Risks
Rutgers Cancer Institute of New Jersey

Mariam F. Eskander, MD, MPH, surgical oncologist at Rutgers Cancer Institute of New Jersey, the state’s leading cancer center only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, together with RWJBarnabas Health, and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School whose clinical expertise includes liver tumors, shares more information on liver cancer and excessive alcohol use.

Newswise: Breast Cancer Screening: Understanding Risk and Age
Released: 30-Sep-2022 3:05 PM EDT
Breast Cancer Screening: Understanding Risk and Age
Rutgers Cancer Institute of New Jersey

The two most significant risk factors for developing breast cancer include being a woman and increasing age. Michele Blackwood, MD, FACS, is Chief, Section of Breast Surgery at Rutgers Cancer Institute of New Jersey, discusses mammograms for women over 70.

Newswise: Oncoplasty: Breast Cancer Surgery with Cosmetic Results
Released: 30-Sep-2022 3:05 PM EDT
Oncoplasty: Breast Cancer Surgery with Cosmetic Results
Rutgers Cancer Institute of New Jersey

Women with breast cancer have more options made possible by the dynamic field of oncoplastic surgery, which is a combination of cancer surgery with traditional plastic surgery techniques to remove breast cancers and simultaneously leave the remaining breast as intact as possible.

Newswise:  The Impact of Breast Cancer on the Hispanic/ Latina Community: Answers from an Expert
Released: 30-Sep-2022 3:05 PM EDT
The Impact of Breast Cancer on the Hispanic/ Latina Community: Answers from an Expert
Rutgers Cancer Institute of New Jersey

While there are more options for women diagnosed with breast cancer now more than ever as a result of advances in research and targeted therapies, outcomes vary among women of different races and ethnicities, including people within the Latina and Hispanic community. Gerardo Capo, MD, medical oncologist at Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only National Cancer Institute-Designated Comprehensive Cancer Center, who sees patients at Trinitas Regional Medical Center, an RWJBarnabas Health facility, shares more about what the Hispanic/Latina community should know.

Newswise: Black Women, Breast Cancer and Clinical Trials
Released: 30-Sep-2022 3:05 PM EDT
Black Women, Breast Cancer and Clinical Trials
Rutgers Cancer Institute of New Jersey

Researchers are working to improve outcomes for Black women with breast cancer, the most commonly diagnosed cancer and leading cause of cancer death in this population, according to the American Cancer Society. Coral Omene, MD, PhD, medical oncologist at the Stacy Goldstein Breast Cancer Center and member of the Cancer Health Equity Center of Excellence at Rutgers Cancer Institute shares more on increased participation in clinical trials, which helps find better ways to prevent, diagnose and treat cancer, diversity in breast cancer research, and what Black women need to know.

Newswise: If You Identify as Hispanic or Latino, What Can You Do to Reduce Your Cancer Risk?
Released: 14-Sep-2022 11:15 AM EDT
If You Identify as Hispanic or Latino, What Can You Do to Reduce Your Cancer Risk?
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute expert shares evidence-based cancer information with this population and steps that can be taken now to prevent and reduce risk of disease.

Released: 9-Sep-2022 8:05 AM EDT
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Receive $2Million Grant from Merck Foundation to Advance Equitable Cancer Care in New Jersey
Rutgers Cancer Institute of New Jersey

RWJBarnabas Health, in partnership with Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only National Cancer Institute-Designated Comprehensive Cancer Center, announced today that it is a grantee supported through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the Merck Foundation (the Foundation) and designed to make cancer care more equitable in the United States by helping patients living in underserved communities receive timely access to high-quality, culturally responsive care. RWJBarnabas Health and Rutgers Cancer Institute of New Jersey have been awarded a $2 million grant over five years.

Newswise: New Chief of Blood Disorders Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 7-Sep-2022 8:00 AM EDT
New Chief of Blood Disorders Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Matthew Matasar, MD, MS, as Chief of Blood Disorders at New Jersey’s leading cancer center and the only one in the state designated as a Comprehensive Cancer Center by the National Cancer Institute. In this role, he will oversee the Sections of Hematologic Malignancies; Transplant and Cell Therapy; and Benign Hematology.

Newswise: Do I Need a Prostate Exam?
Released: 6-Sep-2022 3:40 PM EDT
Do I Need a Prostate Exam?
Rutgers Cancer Institute of New Jersey

Thomas L. Jang, MD, MPH, FACS, chief of urologic oncology and director of the Testicular Cancer Program at Rutgers Cancer Institute of New Jersey shares what men need to know.

Newswise: Is Thyroid Cancer Common? And More Questions You Want Answered
Released: 6-Sep-2022 3:35 PM EDT
Is Thyroid Cancer Common? And More Questions You Want Answered
Rutgers Cancer Institute of New Jersey

Amanda M. Laird, MD, FACS, chief of Endocrine Surgery and Toni Beninato, MD, MS, FACS, endocrine surgeons at Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, and faculty in the Department of Surgery at Rutgers Robert Wood Johnson Medical School, answer some common questions about the thyroid.

Newswise: Empowerment through Gynecologic Health Education
Released: 6-Sep-2022 3:35 PM EDT
Empowerment through Gynecologic Health Education
Rutgers Cancer Institute of New Jersey

September is gynecologic cancer awareness month. The empowerment of taking charge of your gynecologic health starts with having the right information and resources, knowing your body and talking openly to your doctors—and each other—about critical health issues.

Newswise: Can a Person with Sickle Cell Disease Live a Normal Life?
Released: 6-Sep-2022 3:35 PM EDT
Can a Person with Sickle Cell Disease Live a Normal Life?
Rutgers Cancer Institute of New Jersey

People who have sickle cell disease (SCD), a genetic disorder that affects red blood cells, have reduced life expectancy and may face many challenges in their life. However, there are steps they can take to live the healthiest life possible despite this disease.

Newswise: Why is CAR T-cell Therapy so Exciting? Answers from an Expert
Released: 6-Sep-2022 2:05 PM EDT
Why is CAR T-cell Therapy so Exciting? Answers from an Expert
Rutgers Cancer Institute of New Jersey

Ira Braunschweig, MD, chief of Transplant and Cell Therapy at Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only National Cancer Institute-Designated Comprehensive Cancer Center, chief of the Transplant and Cell Therapy Service of the RWJBarnabas Health Oncology Service Line, and director of Cell Therapy and Bone Marrow Transplantation at Robert Wood Johnson University Hospital, an RWJBarnabas facility, explains CAR T-cell immunotherapy.

Newswise: My child is immunocompromised. How can I protect their health while they’re in school?
Released: 19-Aug-2022 10:15 AM EDT
My child is immunocompromised. How can I protect their health while they’re in school?
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey expert shares advice on health and wellness as students transition back into the classroom.

Newswise: Helping Students Cope with Cancer in the Family
Released: 19-Aug-2022 10:15 AM EDT
Helping Students Cope with Cancer in the Family
Rutgers Cancer Institute of New Jersey

When a student’s parent, sibling or other key figure in their life has cancer, school attendance and performance, social relationships and behavior can all be impacted. Social workers at Rutgers Cancer Institute of New Jersey offer expert advise on helping your child cope during the upcoming school year.

Newswise: Support Yourself and Others while Experiencing Grief during the Cancer Journey
Released: 12-Aug-2022 11:45 AM EDT
Support Yourself and Others while Experiencing Grief during the Cancer Journey
Rutgers Cancer Institute of New Jersey

Social Worker at Rutgers Cancer Institute of New Jersey shares tips for both patients and caregivers on managing grief during the cancer journey.

Newswise: Unraveling of Genetic Mechanism behind Tumor Formation may Improve Targeted Treatment for Cancer Patients
10-Aug-2022 9:05 AM EDT
Unraveling of Genetic Mechanism behind Tumor Formation may Improve Targeted Treatment for Cancer Patients
Rutgers Cancer Institute of New Jersey

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical responses to available therapies remained variable and unpredictable, making it difficult to select patients who would benefit from these types of treatments. An international team of researchers, including Shridar Ganesan, MD, PhD, chief of molecular oncology and associate director for translational research at Rutgers Cancer Institute of New Jersey, the state’s leading cancer center and only NCI-designated Comprehensive Cancer Center together with RWJBarnabas Health, have found new opportunities to improve diagnostics and targeted therapy for many cancer patients.

Newswise: Enhancing Awareness and Participation of Black Breast Cancer Patients in Clinical Trials
Released: 18-Jul-2022 1:20 PM EDT
Enhancing Awareness and Participation of Black Breast Cancer Patients in Clinical Trials
Rutgers Cancer Institute of New Jersey

Coral Omene, MD, PhD, medical oncologist in the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center together with RWJBarnabas Health, has been awarded a $50,000 grant from the V Foundation for Cancer Research in partnership with ESPN to increase clinical trial awareness and enrollment of Black women with breast cancer.

Newswise: Lifestyle Changes are a Major Factor in Preventing Cancers
Released: 5-Jul-2022 8:05 AM EDT
Lifestyle Changes are a Major Factor in Preventing Cancers
Rutgers Cancer Institute of New Jersey

Evelyn Fuertes, BA, NDTR, community outreach coordinator and member of the Cancer Health Equity Center of Excellence at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, together with RWJBarnabas Health, works to educate communities and providers on cancer prevention.



close
0.23027